Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview
Authors:
- Henri RochefortHRHenri Rochefort
- Marcel GarciaMGMarcel Garcia
- Murielle GlonduMGMurielle Glondu
- Valérie LaurentVLValérie Laurent
- Emmanuelle LiaudetELEmmanuelle Liaudet
- Jean-Marc ReyJRJean-Marc Rey
- Pascal RogerPRPascal Roger
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 291 (2) , 157-170
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The prognostic value of cathepsin D in breast cancer. A long road to the clinicEuropean Journal of Cancer, 1996
- Mitogenic activity of procathepsin D purified from conditioned medium of breast‐cancer cells by affinity chromatography on pepstatinyl agaroseInternational Journal of Cancer, 1994
- Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin DEuropean Journal of Cancer, 1993
- Cathepsin D in breast cancer: A tissue marker associated with metastasisEuropean Journal of Cancer, 1992
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancerJournal of Steroid Biochemistry, 1989
- Cathepsin D inactivates cysteine proteinase inhibitors cystatinsBiochemical and Biophysical Research Communications, 1988
- Lysosomal Enzymes and Their ReceptorsAnnual Review of Biochemistry, 1986
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980
- Role of specific cell surface receptors in thrombin-stimulated cell divisionCell, 1978